Celldex Therapeutics, Inc. Stock Nasdaq
Equities
US15117B1035
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 3.39M | Sales 2025 * | 3.13M | Capitalization | 2.39B |
---|---|---|---|---|---|
Net income 2024 * | -170M | Net income 2025 * | -203M | EV / Sales 2024 * | 622 x |
Net cash position 2024 * | 285M | Net cash position 2025 * | 372M | EV / Sales 2025 * | 646 x |
P/E ratio 2024 * |
-12.5
x | P/E ratio 2025 * |
-11.2
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.65% |
Latest transcript on Celldex Therapeutics, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Tibor Keler
FOU | Founder | 65 | 82-12-31 |
Anthony Marucci
FOU | Founder | 62 | 82-12-31 |
Sam Martin
DFI | Director of Finance/CFO | 53 | 09-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Herbert Conrad
BRD | Director/Board Member | 91 | 08-02-29 |
Cheryl L. Cohen
BRD | Director/Board Member | 58 | 22-06-15 |
Harry H. Penner
BRD | Director/Board Member | 78 | 96-12-31 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |